The University of Manchester, GlaxoSmithKline (GSK) and AstraZeneca have appointed Professor Tracy Hussell as Director of the new Manchester Collaborative Centre for Inflammation Research (MCCIR).
- Medicine - Oct 23 Teeth Tales tells a story
- Microtechnics - Oct 23 Explosion in the ideas factory
- Medicine - Oct 22 Liverpool awarded £5M for new technologies in stratified medicines
- Astronomy - Oct 22 UCL space film evening at Stratford Picture House
- History - Oct 22 Rare First World War military memorabilia goes on display to public
- Medicine - Oct 22 UW to serve as national hub for mentor training as part of diversity consortium
- Architecture - Oct 22 Hashim Sarkis named dean of the School of Architecture and Planning
- Administration - Oct 22 Mission Big Red Flag: Simulated flight, real sweat
- Medicine - Oct 22 U-M chemist receives $2M to map disease- causing ’free radical’ damage
- Social Sciences - Oct 22 Stanford psychologist explores how meaningfulness cultivates well- being over time
- Life Sciences - Oct 22 Genentech pays $150 million for exclusive worldwide licensing agreement with NewLink
- Earth Sciences - Oct 22 Researchers resolve the Karakoram glacier anomaly, a cold case of climate science
- Chemistry - Oct 22 Spectacular science takes over Manchester
- Agronomy - Oct 22 USDA designates Cornell as obesity prevention hub
- Astronomy - Oct 22 Packing for Mars
- Earth Sciences - Oct 22 And now, the volcano forecast
Director appointed for inflammation research centre
The MCCIR is a unique collaboration announced in May last year to establish a world-leading translational centre for inflammatory diseases with an initial investment of £5 million from each partner over a three year period.
Professor Hussell is currently Professor of Inflammatory Disease at the National Heart and Lung Institute at Imperial College London where she has developed a vibrant research group studying immunity, pathology and vaccination in influenza virus infection with a special interest in the secondary bacterial complications that can ensue.
Professor Hussell’s research has identified novel strategies to alleviate inflammatory disorders. Her group has pioneered the concept of, and is still working on, how one inflammatory condition modulates the severity of the next. Importantly, she has identified that the activation of an immune response changes depending on which organ of the body it is in. Understanding tissue specific regulation of immunity reveals novel methods to treat inflammatory disorders.
Professor Hussell said: “This new centre provides a unique opportunity, working not only with the academic and medical resources of Manchester University, but also with pharmaceutical industry. I am very proud to have been chosen to lead the centre and, naturally, I am hugely excited by the prospect of guiding it into a world leading institution for translational research and innovation”.
The MCCIR collaboration between two UK-based pharmaceutical companies, GSK and AstraZeneca, and The University of Manchester, a premier research-led institution, will bring together scientists from both the pharmaceutical industry and academia to work collaboratively on inflammation research and translational medicine.
Speaking of the new appointment, Professor Ian Jacobs, University Vice-President and Dean of the Faculty of Medical and Human Sciences and Chair of the MCCIR Board said: “I am delighted that we have appointed a scientist of Tracy’s quality and reputation to direct MCCIR. This is a unique venture that will link with areas of strength in cancer, inflammatory disease, cardiovascular disease and human development across The University of Manchester and Manchester Academic Health Science Centre. Tracy’s recruitment is a key step in a series of initiatives and appointments which will ensure that MCCIR has an international impact.”
Professor Martin Humphries, University Vice-President and Dean of the Faculty of Life Sciences, added: “The MCCIR is a unique collaboration between AstraZeneca, GSK and the University that aims to deliver ground-breaking basic and translational research in inflammation and inflammatory disease. The initiative therefore requires someone with Tracy’s track record, vision and drive to succeed, and I am delighted that she has agreed to join us to lead the Centre.”
MCCIR Board Member Roberto Solari, from GSK, said: “This partnership between the University, AstraZeneca and GSK is a truly groundbreaking initiative and we are all tremendously excited about Tracy’s appointment as director. We are confident that under her leadership the MCCIR will become an international centre of excellence that will deliver real innovation and ultimately bring benefit to patients.”
Menelas Pangalos, Executive Vice President of Innovative Medicines at AstraZeneca, added: "AstraZeneca recognises the importance of this collaboration with the University and GSK as we need to work and think differently if we are to solve challenging scientific and medical problems underlying inflammatory disease. Tracy’s appointment and her leadership of the MCCIR will enhance our efforts to speed the search for innovative new medicines that could help millions of people."
Professor Hussell is a principal investigator in the Medical Research Council/Asthma UK Centre in Allergic Mechanisms of Asthma, and in the Centre for Respiratory Infection. She is also a member of the research committee for Asthma UK and has contributed significantly to British Immunology as Secretary for the Clinical Immunology and Allergy Section of the Royal Society of Medicine and as the Education Secretary and a Trustee of the British Society for Immunology.
Last job offers
- Life Sciences - 23.10
- Business - 20.10
Dozent / Dozentin mit Forschungserfahrung
- Business - 20.10
Doktorandin / Doktoranden in den Bereichen Raum und Mobilität oder Energie und Mobilität
- Business - 16.10
Assistant Professor in Economics
- Business - 16.10
Assistant Professor in Statistics and Econometrics (big data)
- Computer Science - 16.10
2 PhD positions (Future Internet and localization of wireless devices)
- Medicine - 22.10
Sydney Catalyst Professor / associate Professor in Translational Cancer Research a Professor / associate...
- Business - 22.10
Assistant Professor of Financial Intermediation
- Business - 19.9
UniversitätsprofessorIn für die Stiftungsprofessur "Industrielle Energiesysteme"
- Literature - 17.9
Universitätsprofessur für Anglistische Sprachwissenschaft
- Law - 22.10
Professorship for Public Law
- Law - 22.10
Professur f. Öffentliches Recht
- Business - 22.10
Senior Lecturer / Reader in Operations Management / Business Analytics
- Social Sciences - 22.10
Associate Professorship or Professorship in the Social Anthropology of the Middle East
- Microtechnics - 22.10
Materials Science Engineering & Mechanical Engineering - Assistant Professor (AA8844)
- Administration - 22.10
Associate Professor & Chair, Public Administration